Wang, Kun
Chen, Siyu
Wu, Yue
Wang, Yang
Lu, Yousheng
Sun, Yanzi
Chen, Yijun http://orcid.org/0000-0002-4920-152X
Article History
Received: 13 December 2022
Revised: 4 May 2023
Accepted: 31 May 2023
First Online: 7 June 2023
Competing interests
: The authors declare no competing interests.
: All procedures followed were in accordance with recognized ethical guidelines and responsible committee. The studies carried out on human specimens were conducted in accordance with ethical guidelines and approved by an institutional ethical review board of Jiangsu Cancer Hospital, and informed consent was obtained from each patient. All animal welfares and ethics as well as experimental protocols were approved and conducted in accordance with the Institutional Animal Care and Use Committee at China Pharmaceutical University.
: The authors affirm that tumor tissue analysis participants provided informed consent for publication of the result in Fig. InternalRef removedD.